98%
921
2 minutes
20
Davidson KW, Barry MJ, Mangione CM, et al. JAMA. 2022;327:1577-84. 35471505.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.7326/J22-0064 | DOI Listing |
JAMA Netw Open
September 2025
Department of Urology, Center for Health Outcomes Research and Dissemination, University of Washington, Seattle.
Importance: Black individuals have a twofold higher rate of prostate cancer death in the US compared with the average population with prostate cancer. Few guidelines support race-conscious screening practices among at-risk Black individuals.
Objective: To examine structural factors that facilitate or impede access to prostate cancer screening among Black individuals in the US.
Cureus
July 2025
Department of Population Health, NYU Grossman School of Medicine, New York City, USA.
Background: The United States Preventive Services Task Force (USPSTF) provides age-based recommendations for prostate cancer screening. Such a single-criterion strategy can not only miss aggressive cancers that occur before the designated cut-off age, but also over-screen men whose cancers occur at a much older age. A multi-factorial model incorporating a wide spectrum of medical history may offer more accurate predictions.
View Article and Find Full Text PDFJ Natl Med Assoc
August 2025
Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Objectives: To evaluate changes in preterm birth (PTB) rates in the U.S. following the United States Preventive Services Task Force (USPSTF) aspirin recommendation guidelines.
View Article and Find Full Text PDFStud Health Technol Inform
August 2025
School of Nursing, Indiana University, Indiana, USA.
Most healthcare systems worldwide are designed to be reactive. According to the U.S.
View Article and Find Full Text PDFCrit Rev Clin Lab Sci
August 2025
Laboratory Medicine and Pathobiology, University of Toronto, ON, Canada.
Population screening is an effective strategy for disease prevention, early diagnosis and treatment; however, the benefits and harms of disease screening need to be carefully evaluated before clinical implementation. Various national and international bodies, including the U.S.
View Article and Find Full Text PDF